| Oct 15, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | PurchaseSEC code PEffective Oct 13, 2026 · transaction dateReported units 100,000 shares · reported price 8.3548 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 1,027,000 shares | 4 filing0001045463-26-000021 |
| Oct 15, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | PurchaseSEC code PEffective Oct 14, 2026 · transaction dateReported units 10,000 shares · reported price 8.4569 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 1,037,000 shares | 4 filing0001045463-26-000021 |
| Sep 21, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | PurchaseSEC code PEffective Sep 18, 2026 · transaction dateReported units 100,000 shares · reported price 8.4346 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 927,000 shares | 4 filing0001045463-26-000016 |
| Sep 3, 2026Latest represented filing date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | Current covered snapshot10% ownerValuation observation Sep 25, 2026 | Ordinary Shares, par value $0.01 per share: 827,000 sharesCurrent covered company value: $6.86M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Sep 3, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | PurchaseSEC code PEffective Sep 2, 2026 · transaction dateReported units 27,000 shares · reported price 9.4718 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 827,000 shares | 4 filing0001045463-26-000015 |
| Aug 21, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | PurchaseSEC code PEffective Aug 20, 2026 · transaction dateReported units 50,000 shares · reported price 8.7886 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 800,000 shares | 4 filing0001045463-26-000014 |
| Aug 18, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | AcquisitionSEC code GEffective Aug 17, 2026 · transaction dateReported units 336,000 shares · reported price 0 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 1,377,553 shares | 4 filing0001045463-26-000013 |
| Aug 18, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | DispositionSEC code GEffective Aug 18, 2026 · transaction dateReported units 627,553 shares · reported price 0 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 750,000 shares | 4 filing0001045463-26-000013 |
| Aug 11, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | AcquisitionSEC code GEffective Aug 10, 2026 · transaction dateReported units 251,553 shares · reported price 0 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 1,041,553 shares | 4 filing0001045463-26-000011 |
| Aug 10, 2026Filed date | PROTHENA CORP PUBLIC LTD CO (PRTA)Nasdaq | PurchaseSEC code PEffective Aug 7, 2026 · transaction dateReported units 34,000 shares · reported price 8.6192 | Ordinary Shares, par value $0.01 per shareReported position after transaction: 790,000 shares | 4 filing0001045463-26-000010 |